The prognostic role of baseline 18F-FDG PET/CT SUVmax and SUVmax change in patients with node-positive breast cancer receiving neoadjuvant chemotherapy
Publication date: Available online 15 April 2021Source: Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)Author(s): Canan Can, Nadiye Akdeniz, Halil Kömek, Cihan Gündoğan, Zuhat Urakçı, Abdurrahman Işıkdoğan
Source: Revista Espanola de Medicina Nuclear e Imagen Molecular - Category: Nuclear Medicine Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Nuclear Medicine